Man Group PLC Abbott Laboratories Put Options Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $2.29 Million - $2.71 Million	22,900 Added 52.52%	66,500 $7.58 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $543,942 - $607,176	5,400 Added 14.14%	43,600 $4.53 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.02 Million - $1.12 Million	9,300 Added 32.18%	38,200 $4.34 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $2.61 Million - $3.19 Million	28,900 New	28,900 $3.18 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $21,158 - $24,906	200 New	200 $23,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.